IL150882A0 - Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents - Google Patents
Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agentsInfo
- Publication number
- IL150882A0 IL150882A0 IL15088201A IL15088201A IL150882A0 IL 150882 A0 IL150882 A0 IL 150882A0 IL 15088201 A IL15088201 A IL 15088201A IL 15088201 A IL15088201 A IL 15088201A IL 150882 A0 IL150882 A0 IL 150882A0
- Authority
- IL
- Israel
- Prior art keywords
- arylpiperidines
- arylpiperazines
- inhibiting agents
- metalloproteinase inhibiting
- metalloproteinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00400469 | 2000-02-21 | ||
| PCT/GB2001/000616 WO2001062751A1 (en) | 2000-02-21 | 2001-02-15 | Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL150882A0 true IL150882A0 (en) | 2003-02-12 |
Family
ID=8173566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15088201A IL150882A0 (en) | 2000-02-21 | 2001-02-15 | Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20030139419A1 (ko) |
| EP (1) | EP1261595A1 (ko) |
| JP (1) | JP2003524008A (ko) |
| KR (1) | KR20020079882A (ko) |
| CN (1) | CN1404474A (ko) |
| AU (1) | AU3385401A (ko) |
| BR (1) | BR0108500A (ko) |
| CA (1) | CA2396971A1 (ko) |
| IL (1) | IL150882A0 (ko) |
| MX (1) | MXPA02008112A (ko) |
| NO (1) | NO20023951D0 (ko) |
| WO (1) | WO2001062751A1 (ko) |
| ZA (1) | ZA200205845B (ko) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0119473D0 (en) * | 2001-08-09 | 2001-10-03 | Astrazeneca | Compounds |
| GB0119472D0 (en) * | 2001-08-09 | 2001-10-03 | Astrazeneca Ab | Compounds |
| GB0119474D0 (en) | 2001-08-09 | 2001-10-03 | Astrazeneca Ab | Compounds |
| CA2479906C (en) | 2002-04-03 | 2011-02-08 | Topotarget Uk Limited | Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| TW200410923A (en) * | 2002-10-17 | 2004-07-01 | Ono Pharmaceutical Co | Therapeutic agent for chronic obstructive pulmonary disease |
| US7465719B2 (en) | 2003-01-17 | 2008-12-16 | Topotarget Uk Limited | Carbamic acid compounds comprising an ester or ketone linkage as HDAC inhibitors |
| NZ541064A (en) | 2003-03-07 | 2007-09-28 | Kowa Co | Benzofuran derivative |
| CA2528317A1 (en) * | 2003-06-19 | 2004-12-29 | Celltech R & D Limited | Hydroxamate sulfonamides as cd23 shedding inhibitors |
| US20060241118A1 (en) * | 2004-06-18 | 2006-10-26 | Celltech R&D Limited | Hydroxamate sulfonamides as cd23 shedding inhibitors |
| KR100838645B1 (ko) * | 2006-09-28 | 2008-06-16 | 한국화학연구원 | 베타-세크리테아제 활성을 억제하는 피페리딘 화합물 |
| WO2020070239A1 (en) | 2018-10-04 | 2020-04-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Egfr inhibitors for treating keratodermas |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU730464B2 (en) * | 1996-08-07 | 2001-03-08 | Darwin Discovery Limited | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| WO1998016514A1 (en) * | 1996-10-16 | 1998-04-23 | American Cyanamid Company | Ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| GB9725782D0 (en) * | 1997-12-05 | 1998-02-04 | Pfizer Ltd | Therapeutic agents |
| EP1107953A1 (en) * | 1998-08-29 | 2001-06-20 | British Biotech Pharmaceuticals Limited | Hydroxamic acid derivatives as proteinase inhibitors |
| GB9919776D0 (en) * | 1998-08-31 | 1999-10-27 | Zeneca Ltd | Compoujnds |
-
2001
- 2001-02-15 AU AU33854/01A patent/AU3385401A/en not_active Abandoned
- 2001-02-15 BR BR0108500-0A patent/BR0108500A/pt not_active IP Right Cessation
- 2001-02-15 CN CN01805387A patent/CN1404474A/zh active Pending
- 2001-02-15 JP JP2001562533A patent/JP2003524008A/ja active Pending
- 2001-02-15 US US10/204,389 patent/US20030139419A1/en not_active Abandoned
- 2001-02-15 CA CA002396971A patent/CA2396971A1/en not_active Abandoned
- 2001-02-15 IL IL15088201A patent/IL150882A0/xx unknown
- 2001-02-15 KR KR1020027010847A patent/KR20020079882A/ko not_active Application Discontinuation
- 2001-02-15 WO PCT/GB2001/000616 patent/WO2001062751A1/en not_active Application Discontinuation
- 2001-02-15 MX MXPA02008112A patent/MXPA02008112A/es unknown
- 2001-02-15 EP EP01905883A patent/EP1261595A1/en not_active Withdrawn
-
2002
- 2002-07-22 ZA ZA200205845A patent/ZA200205845B/en unknown
- 2002-08-20 NO NO20023951A patent/NO20023951D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20020079882A (ko) | 2002-10-19 |
| CA2396971A1 (en) | 2001-08-30 |
| CN1404474A (zh) | 2003-03-19 |
| NO20023951L (no) | 2002-08-20 |
| US20030139419A1 (en) | 2003-07-24 |
| BR0108500A (pt) | 2003-04-29 |
| MXPA02008112A (es) | 2002-11-29 |
| ZA200205845B (en) | 2003-10-22 |
| JP2003524008A (ja) | 2003-08-12 |
| EP1261595A1 (en) | 2002-12-04 |
| NO20023951D0 (no) | 2002-08-20 |
| WO2001062751A1 (en) | 2001-08-30 |
| AU3385401A (en) | 2001-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI318207B (en) | Carbamate caspase inhibitors and uses thereof | |
| PL357713A1 (en) | Caspase inhibitors and uses thereof | |
| EG23122A (en) | Pyrrolcarboxamides and pyrrolcarbothioamides | |
| AU9667901A (en) | Mycoattractants and mycopesticides | |
| HUP0300855A3 (en) | Peptidmomimetic protease inhibitors, pharmaceutical compositions and their use | |
| MXPA03004714A (es) | Sales de una isotiazol-4-carboxamida y su uso como agentes de antihiperproliferacion. | |
| GB0021885D0 (en) | New use | |
| AU8420301A (en) | Use | |
| IL150882A0 (en) | Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents | |
| AU5693101A (en) | New thiochromane derivatives and their use as thrombin inhibitors | |
| PL359668A1 (en) | Biphenyl derivatives and the use thereof as integrin inhibitors | |
| GB0007530D0 (en) | Trityl-type compounds and their use | |
| GB0021497D0 (en) | Compounds and their use | |
| AU2001232113A1 (en) | Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) | |
| GB0006864D0 (en) | New use | |
| IL152474A0 (en) | Antihypertensive agents and use | |
| GB0021668D0 (en) | New use | |
| AU2002321974A1 (en) | Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents | |
| AU2002321973A1 (en) | Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents | |
| AU2002324395A1 (en) | Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents | |
| GB0004183D0 (en) | New use | |
| AU5104101A (en) | Composition and use | |
| AU8973201A (en) | Biphenyl derivatives and the use thereof as integrin inhibitors | |
| GB0027181D0 (en) | New use | |
| SI1268425T1 (sl) | Zaviralci karbamat kaspaze in uporaba le-teh |